Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > バイオシミラー

Anti-Human EGFR & LGR5 Bispecific Reference Antibody (Petosemtamab, RUO) (HF004186)

Anti-Human EGFR & LGR5 Bispecific Reference Antibody (Petosemtamab, RUO)
Anti-Human EGFR & LGR5 Bispecific Reference Antibody (Petosemtamab, RUO)
Anti-Human EGFR & LGR5 Bispecific Reference Antibody (Petosemtamab, RUO)
Anti-Human EGFR & LGR5 Bispecific Reference Antibody (Petosemtamab, RUO)
Anti-Human EGFR & LGR5 Bispecific Reference Antibody (Petosemtamab, RUO)
Anti-Human EGFR & LGR5 Bispecific Reference Antibody (Petosemtamab, RUO)
価格(USD):
スペック:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号HF004186
説明
Petosemtamab (HF004186) is a research-grade recombinant antibody targeting HER1. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
種反応性Human
アプリケーションELISA, Bioactivity: FCM, Functional assay, Research in vivo
宿主種Human
クローン性Monoclonal
アイソタイプIgG1-kappa
テスト済みアプリケーション FCM
ターゲット EC:2.7.10.1, EGFR, ERBB, ERBB1, Epidermal growth factor receptor, HER1, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, G protein-coupled receptor 49, G protein-coupled receptor 67, G protein-coupled receptor HG38, GPR49, GPR67, LGR5, Leucine-rich repeat-containing G protein-coupled receptor 5
エンドトキシンレベル < 10 EU/mg
純度 >95% as determined by SDS-PAGE.
精製 Protein A/G purified from cell culture supernatant.
アクセッション番号 P00533 & O75473
形態 Liquid
保存バッファー 0.01M PBS pH 7.4.

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

安定性と保存 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
別名Bispecific, MCLA-158, 2213450-26-9
背景Petosemtamab (MCLA 158) is an anti- EGFR (Kd: 0.22 nM) and anti-LGR5 (Kd: 0.86 nM) monoclonal antibody (mAb). Petosemtamab leads to EGFR signaling blockade and receptor degradation in LGR5+ cancer cells. Petosemtamab can be used in the research of solid tumors, such as head and neck squamous cell carcinoma (HNSCC), metastatic colorectal cancer (CRC).
注意事項 For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507)
イメージ
  • Anti-Human EGFR & LGR5 Bispecific Reference Antibody (Petosemtamab, RUO)

    Bioactivity

    SEC-HPLC detection for Research Grade Petosemtamab.

  • Anti-Human EGFR & LGR5 Bispecific Reference Antibody (Petosemtamab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Petosemtamab.

  • Anti-Human EGFR & LGR5 Bispecific Reference Antibody (Petosemtamab, RUO)

    Flow CytoMetry

    Flow-cytometry using PE anti-human EGFR&LGR5 antibody. HepG-2 cells were stained with an irrelevant antibody (Blue Histogram) or an PE anti-human EGFR&LGR5 monoclonal antibody (Catalog: HF004186, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, and cells analysed on a NovoCyte Flow Cytometer.

参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト